Literature DB >> 11143845

Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti HCV) in Madurai, south India.

S Chandrasekaran1, N Palaniappan, V Krishnan, G Mohan, N Chandrasekaran.   

Abstract

(1) The positivity of HBsAg was 4% (75/1819) whereas anti HCV was present only in 0.75% (27/3574) of blood donors. (2) 5.3% (4/75) of hospital staff had HBsAg alone in their blood samples. One doctor, one Staff nurse, one Lascar and one Sanitary worker were positive for HBsAg. None of them were positive for anti HBcIgm and anti-HCV. (3) 29% (31/115) of suspected hepatitis cases were positive for any one of the viral markers or both. 21% (15/72) of males and 14% (6/43) of females were positive for HBsAg. Whereas only 4% (3/72) of males and 2% (1/43) of females were positive for anti HCW. Both HBsAg and anti HCV were found in 8% (6/72) of males only. The age group predominantly, i.e. in 29 out of 31 cases found positive for HBsAg and/or anti HCV, was above 15 years. Two remaining HBsAg positive cases belonged to the 5 to 14 years age group. 71% (84/115) of suspected hepatitis cases were negative for both HBsAg and anti HCV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11143845

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  8 in total

Review 1.  Hepatitis C in India.

Authors:  Ashis Mukhopadhyaya
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

Review 2.  Calculating prevalence of hepatitis B in India: using population weights to look for publication bias in conventional meta-analysis.

Authors:  Ashish Batham; Manoj Anand Gupta; Pallav Rastogi; Shubham Garg; V Sreenivas; Jacob M Puliyel
Journal:  Indian J Pediatr       Date:  2010-01-28       Impact factor: 1.967

3.  Hepatitis C, a silent threat to the community of Haryana, India: a community-based study.

Authors:  Ramesh Verma; Binod Kumar Behera; R B Jain; Varun Arora; Vinod Chayal; P S Gill
Journal:  Australas Med J       Date:  2014-01-31

Review 4.  Tackling the Hepatitis B Disease Burden in India.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-12-15

5.  Seroprevalence of hepatitis B in healthy blood donors attending tertiary care hospital (SKIMS Soura, Srinagar): a prospective study of 1 year.

Authors:  Mohd Younus Shah; Faisal Younis Shah; Faizan Younis Shah; Muzaffer Naik
Journal:  Indian J Gastroenterol       Date:  2013-07

Review 6.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Rakesh Aggarwal; Shivram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoorz; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Shiv K Sarin; Samir Shah; P K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-09

7.  The current seroprevalence of hepatitis C virus in a tertiary care centre in vellore, Tamil Nadu.

Authors:  V Gowri; C Chandraleka; R Vanaja
Journal:  Indian J Community Med       Date:  2012-04

8.  Seroprevalence of anti-HCV antibodies among blood donors of north India.

Authors:  R N Makroo; Rimpreet Singh Walia; Mohit Chowdhry; Aakanksha Bhatia; Vikas Hegde; N L Rosamma
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.